Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Outlook Therapeutics (OTLK) over the last 8 years, with Q4 2025 value amounting to 2.11.

  • Outlook Therapeutics' Equity Ratio rose 2852.64% to 2.11 in Q4 2025 from the same period last year, while for Dec 2025 it was 2.11, marking a year-over-year increase of 2852.64%. This contributed to the annual value of 1.73 for FY2025, which is N/A changed from last year.
  • Latest data reveals that Outlook Therapeutics reported Equity Ratio of 2.11 as of Q4 2025, which was up 2852.64% from 1.73 recorded in Q3 2025.
  • In the past 5 years, Outlook Therapeutics' Equity Ratio ranged from a high of 1.66 in Q2 2025 and a low of 2.96 during Q4 2024